KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hologic (HOLX) EBT (2016 - 2025)

Hologic's EBT history spans 17 years, with the latest figure at $229.7 million for Q4 2025.

  • For Q4 2025, EBT fell 7.19% year-over-year to $229.7 million; the TTM value through Dec 2025 reached $663.4 million, down 27.99%, while the annual FY2025 figure was $681.2 million, 21.26% down from the prior year.
  • EBT for Q4 2025 was $229.7 million at Hologic, up from $227.2 million in the prior quarter.
  • Across five years, EBT topped out at $780.5 million in Q1 2021 and bottomed at -$28.5 million in Q1 2025.
  • The 5-year median for EBT is $237.0 million (2022), against an average of $278.4 million.
  • The largest annual shift saw EBT skyrocketed 1889.26% in 2024 before it plummeted 113.48% in 2025.
  • A 5-year view of EBT shows it stood at $621.9 million in 2021, then plummeted by 61.55% to $239.1 million in 2022, then fell by 19.99% to $191.3 million in 2023, then rose by 29.38% to $247.5 million in 2024, then fell by 7.19% to $229.7 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's EBT are $229.7 million (Q4 2025), $227.2 million (Q3 2025), and $235.0 million (Q2 2025).